Autres langues Know Labs, Inc.

Actions

KNW

US4992381032

Temps Différé Nyse Autres places de cotation 18:42:13 27/06/2024			Varia. 5j.	Varia. 1 janv.
0,4865 ^USD	+1,35 %		-6,44 %	-4,42 %

22/06	Know Labs, Inc. Annonce de nouveaux résultats intermédiaires d'une étude clinique	CI
16/05	Know Labs, Inc. annonce la nomination de Chris Somogyi au poste de président international	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Know Labs to Present at the American Diabetes Association’s Scientific Sessions	22/06
Know Labs, Inc. Announces Further Interim Results from a Clinical Research Study	22/06
Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University	05/06
Know Labs Appoints Chris Somogyi as President, International	16/05
Know Labs, Inc. Announces the Appointment of Chris Somogyi as President, International	16/05
Know Labs, Inc. Reports Second Quarter FY 2024 Results	15/05
Know Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	15/05
Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting	09/05
Know Labs, Inc. to Present Clinical Research At the 2024 American Association of Clinical Endocrinology Annual Meeting	09/05
Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024	08/05
Know Labs to Present Clinical Research at the 2024 American Physiology Summit	08/04
Know Labs to Present Clinical Research at the 2024 American Physiology Summit	05/04
Certain Common Stock of Know Labs, Inc. are subject to a Lock-Up Agreement Ending on 27-MAR-2024.	27/03
Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study	06/03
Know Labs, Inc. Announces Interim Results from its Most Recent Clinical Research Study	06/03
Know Labs Announces the KnowU, its Wearable Non-Invasive Continuous Glucose Monitor	28/02
Know Labs, Inc. announced that it expects to receive $12 million in funding from The Lind Partners, LLC	27/02
Know Labs, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	14/02
Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)	24/01
"2024 Market Outlook: SmallCap Radar Stocks Unveiled": DYAI, SKYX, QUBT, KNW, VTAK	28/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Know Labs, Inc.

Actions

KNW

US4992381032

Autres langues

Filtres